Loading...
•
Oct 31, 2020
Korn Ferry Q2 2021 Earnings Report
Korn Ferry's financial performance rebounded sharply in Q2 2021, with revenue up 27% sequentially and improved earnings and profitability.
Key Takeaways
Korn Ferry reported a strong second quarter with fee revenue of $435.4 million, a 27% increase sequentially. Net income attributable to Korn Ferry was $27.8 million, with an operating margin of 11.1%. Adjusted EBITDA was $66.2 million, with an adjusted EBITDA margin of 15.2%.
Fee revenue was $435.4 million, a decrease of 12% year-over-year but a 27% increase sequentially.
Net income attributable to Korn Ferry was $27.8 million.
Operating income was $48.2 million, with an operating margin of 11.1%.
Diluted earnings per share was $0.51, and adjusted diluted earnings per share was $0.54.
Revenue by Segment
Forward Guidance
Due to the uncertainty caused by COVID-19, Korn Ferry will not issue specific revenue or earnings guidance for the third quarter of FY'21.
Positive Outlook
- Announcements around vaccines that have greater than 90% effectiveness.
- The world has adopted new ways of working and interacting with substantial acceptance of business being conducted in a virtual world.
Challenges Ahead
- Unanswered questions regarding the capacity to manufacture the vaccines at scale.
- Unanswered questions regarding how vaccines will be distributed and administered to the population at large.
- Governments are putting lockdowns back in place as the number of COVID-19 cases and hospitalizations reach all-time highs.
- Constantly evolving and unprecedented nature of what we are currently experiencing.
- Ever-changing datapoints continues to cloud the near-term predictability of our business.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...